Rectal Signet Ring Cell Adenocarcinoma
4 clinical trials · Condition
◉ Watch Rectal Signet Ring Cell Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT01802320) | National Cancer Institute (NCI) | 2013-03-01 |
| Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer (NCT01198535) | National Cancer Institute (NCI) | 2010-09-01 |
| Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer (NCT00745134) | M.D. Anderson Cancer Center | 2008-08-11 |
| Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer (NCT00068692) | National Cancer Institute (NCI) | 2003-10-15 |
Track Rectal Signet Ring Cell Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.